Key Points
- Danaher CAO Christopher Bouda sold 7,598 shares at an average price of $234.56, totaling approximately $1.78 million and reducing his position by 45.48%.
- Danaher reported quarterly EPS of $2.11, beating estimates of $1.92, while revenue rose 8.3% year over year to $6.55 billion.
- Analysts maintain a favorable outlook, with a consensus “Moderate Buy” rating and an average price target of $242.91; the company also declared a quarterly dividend of $0.40 per share.
Danaher Corporation (NYSE:DHR - Get Free Report) CAO Christopher Bouda sold 7,598 shares of the stock in a transaction that occurred on Wednesday, October 28th. The shares were sold at an average price of $234.56, for a total value of $1,782,186.88. Following the transaction, the chief accounting officer owned 9,107 shares in the company, valued at approximately $2,136,137.92. This trade represents a 45.48% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.
Danaher Trading Up 1.2%
NYSE:DHR opened at $236.77 on Friday. The company's 50 day moving average is $218.59 and its 200-day moving average is $201.81. The company has a quick ratio of 1.29, a current ratio of 1.63 and a debt-to-equity ratio of 0.45. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80. The firm has a market cap of $166.58 billion, a price-to-earnings ratio of 38.75, a P/E/G ratio of 2.94 and a beta of 0.76.
Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings data on Wednesday, October 21st. The conglomerate reported $2.11 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.92 by $0.19. Danaher had a net margin of 16.91% and a return on equity of 11.17%. The business had revenue of $6.55 billion during the quarter, compared to the consensus estimate of $6.56 billion. During the same period in the prior year, the firm earned $1.89 EPS. Danaher's quarterly revenue was up 8.3% compared to the same quarter last year. Equities analysts anticipate that Danaher Corporation will post 8.59 EPS for the current year.
Danaher Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be given a dividend of $0.40 per share. The ex-dividend date of this dividend is Wednesday, September 30th. This represents a $1.60 dividend on an annualized basis and a yield of 0.7%. Danaher's payout ratio is currently 26.19%.
Institutional Trading of Danaher
Hedge funds have recently bought and sold shares of the stock. Main Street Group LTD bought a new position in Danaher during the first quarter valued at about $25,000. N.E.W. Advisory Services LLC acquired a new position in Danaher in the 2nd quarter valued at approximately $25,000. Marquette Asset Management LLC lifted its position in shares of Danaher by 192.1% in the 3rd quarter. Marquette Asset Management LLC now owns 111 shares of the conglomerate's stock worth $25,000 after acquiring an additional 73 shares during the period. Evolution Wealth Management Inc. lifted its position in shares of Danaher by 208.0% in the 1st quarter. Evolution Wealth Management Inc. now owns 154 shares of the conglomerate's stock worth $29,000 after acquiring an additional 104 shares during the period. Finally, Field & Main Bank acquired a new stake in shares of Danaher during the 2nd quarter worth approximately $29,000. 79.05% of the stock is owned by institutional investors.
Wall Street Analysts Forecast Growth
DHR has been the topic of several research analyst reports. Robert W. Baird raised their price target on Danaher from $246.00 to $254.00 and gave the company an "outperform" rating in a research report on Thursday, October 22nd. TD Cowen increased their target price on Danaher from $255.00 to $270.00 and gave the company a "buy" rating in a research note on Thursday, October 22nd. Wall Street Zen raised Danaher from a "hold" rating to a "buy" rating in a report on Monday. JPMorgan Chase & Co. lifted their price target on Danaher from $250.00 to $270.00 and gave the stock an "overweight" rating in a research report on Thursday, October 22nd. Finally, Evercore reaffirmed an "outperform" rating and issued a $230.00 price target on shares of Danaher in a research report on Monday, July 6th. Eighteen equities research analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat.com, Danaher presently has a consensus rating of "Moderate Buy" and an average target price of $242.91.
Read Our Latest Stock Analysis on Danaher
Danaher Company Profile
(
Get Free Report)
Danaher Corporation (NYSE: DHR) is a global science and technology company that develops products, services and solutions for the life sciences, biotechnology and diagnostics markets. Its offerings help researchers, pharmaceutical and biotechnology companies, healthcare providers and other organizations conduct scientific research, develop and manufacture medicines, and diagnose disease.
The company operates through businesses that provide bioprocessing equipment and technologies, laboratory instruments, consumables, analytical tools and clinical diagnostic systems.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
